EARY; Charles Todd

Patent Applications and Registrations

Patent applications and USPTO patent grants for EARY; Charles Todd.The latest application filed is for "formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- bonitrile".

Company Profile

8.8.15

EARY; Charles Todd - Longmont CO
EARY; Charles Todd - Stamford CT
Eary; Charles Todd - Boulder CO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Formulations Of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- Bonitrile App 20220202788 - REYNOLDS; Mark ; et al.	2022-06-30
Formulations Of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- Bonitrile App 20220087988 - REYNOLDS; Mark ; et al.	2022-03-24
Process for the preparation of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrim- idin-3-yl)-3-hydroxypyrrolidine-1-carboxamide and salts thereof Grant 11,214,571 - Reynolds , et al. January 4, 2	2022-01-04
Process For The Preparation Of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- Bonitrile App 20210380609 - EARY; Charles Todd ; et al.	2021-12-09
Spray-dried Dispersions, Formulations, And Polymorphs Of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-tr- Ifluoropropan-2-yl)-1h-pyrazole-4-carboxamide App 20210330643 - Brandhuber; Barbara J. ; et al.	2021-10-28
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- bontrile Grant 11,098,064 - Eary , et al. August 24, 2	2021-08-24
Process for the preparation of pyrazolo[1,5-a]pyrimidines and salts thereof Grant 11,091,486 - Zhao , et al. August 17, 2	2021-08-17
Formulations Of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- Bonitrile App 20210077474 - REYNOLDS; Mark ; et al.	2021-03-18
Process For The Preparation Of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- Bonitrile App 20200308194 - EARY; Charles Todd ; et al.	2020-10-01
Formulations of 6-(2-hydroxy-2-methylpropxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-- diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-A]pyridine-3-carb- onitrile Grant 10,786,489 - Reynolds , et al. September 29, 2	2020-09-29
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- bonitrile Grant 10,745,419 - Eary , et al. A	2020-08-18
PROCESS FOR THE PREPARATION OF PYRAZOLO[1,5-a]PYRIMIDINES AND SALTS THEREOF App 20200216451 - Zhao; Qian ; et al.	2020-07-09
Formulations Of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyrid App 20190262322 - Reynolds; Mark ; et al.	2019-08-29
Formulations Of A Macrocyclic Trk Kinase Inhibitor App 20190247398 - Zhao; Qian ; et al.	2019-08-15
Process For The Preparation Of (s)-n-(5-((r)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrim- Idin-3-yl)-3-hydroxypy App 20190218222 - Reynolds; Mark ; et al.	2019-07-18
Process For The Preparation Of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- Bonitrile App 20190106438 - Eary; Charles Todd ; et al.	2019-04-11
8-substituted benzoazepines as toll-like receptor modulators Grant 8,304,407 - Doherty , et al. November 6, 2	2012-11-06
Kinase inhibitors and methods of use thereof Grant 8,044,083 - Groneberg , et al. October 25, 2	2011-10-25
Kinase inhibitors and methods of use thereof Grant 8,039,639 - Groneberg , et al. October 18, 2	2011-10-18
Kinase Inhibitors And Methods Of Use Thereof App 20110124878 - Groneberg; Robert ; et al.	2011-05-26
Kinase Inhibitors And Methods Of Use Thereof App 20090023795 - Groneberg; Robert ; et al.	2009-01-22
Inhibitors of cholesterol ester transfer protein App 20060270675 - Groneberg; Robert D. ; et al.	2006-11-30
Inhibitors of cholesteryl ester transfer protein App 20050282812 - Jones, Zachary ; et al.	2005-12-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.